![Mukund Pandurang Ranade](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mukund Pandurang Ranade
Keine laufenden Positionen mehr
Profil
Mr. Mukund Pandurang Ranade is Executive Director at Emcure Pharmaceuticals Ltd.
He is on the Board of Directors at Emcure Pharmaceuticals Ltd.
Mr. Ranade was previously employed as General Manager-Marketing by GlaxoSmithKline Pharmaceuticals Ltd.
and a Principal by Kewalram Chanrai Group.
He also served on the board at Emcure Pharma UK Ltd.
He received his undergraduate degree from the University of Mumbai.
Ehemalige bekannte Positionen von Mukund Pandurang Ranade
Unternehmen | Position | Ende |
---|---|---|
Kewalram Chanrai Group
![]() Kewalram Chanrai Group TextilesProcess Industries Kewalram Chanrai Group manufactures, trades and distributes general consumer goods. Its products include textiles, automotives, agricultural and waste management products, computer peripherals, and consumer electronics. The company was founded in 1948 and is headquartered in Singapore. | Corporate Officer/Principal | - |
Emcure Pharma UK Ltd.
![]() Emcure Pharma UK Ltd. Medical DistributorsDistribution Services Part of Emcure Pharmaceuticals Ltd., Emcure Pharma UK Ltd. is a wholesaler of pharmaceutical products. The company is based in Luton, UK. | Direktor/Vorstandsmitglied | - |
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Vertrieb & Marketing | - |
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Direktor/Vorstandsmitglied | - |
Ausbildung von Mukund Pandurang Ranade
University of Mumbai | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Health Technology |
Private Unternehmen | 3 |
---|---|
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |
Emcure Pharma UK Ltd.
![]() Emcure Pharma UK Ltd. Medical DistributorsDistribution Services Part of Emcure Pharmaceuticals Ltd., Emcure Pharma UK Ltd. is a wholesaler of pharmaceutical products. The company is based in Luton, UK. | Distribution Services |
Kewalram Chanrai Group
![]() Kewalram Chanrai Group TextilesProcess Industries Kewalram Chanrai Group manufactures, trades and distributes general consumer goods. Its products include textiles, automotives, agricultural and waste management products, computer peripherals, and consumer electronics. The company was founded in 1948 and is headquartered in Singapore. | Process Industries |